Umberto Policlinico di Roma
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Toni, Danilo
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Terminated
3
535
Europe, Canada, Japan, US, RoW
BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo
Remedy Pharmaceuticals, Inc.
Brain Edema, Stroke, Acute
08/23
08/23
DOWN-SUITE, NCT06297863: Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke

Not yet recruiting
2
118
Europe
HEAD DOWN TILT -10° to -15°
University of Milano Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Azienda Ospedaliero-Universitaria Careggi, Firenze, Azienda Ospedaliera Universitaria Gaetano Martino, Messina, Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy, Università degli Studi dell'Aquila, Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma
Acute Ischemic Stroke
09/26
12/26
ELAN, NCT03148457: Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Completed
N/A
2013
Europe, Japan, RoW
Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®), Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Insel Gruppe AG, University Hospital Bern
Ischaemic Stroke
12/22
05/23
COLOSSEO, NCT05379413: Observational Longitudinal Study on the Outbreak and Management of Stroke Related Spasticity

Not yet recruiting
N/A
960
Europe
Botulinum toxin type A
Campus Bio-Medico University
Spasticity as Sequela of Stroke
06/25
06/25

Download Options